This mouse monoclonal antibody was generated against a synthetic three-component O-linked N-acetylglucosamine (O-GlcNAc) immunogen and recognizes GluNAc pepetide/O-GlcNAc.
The study of O-GlcNAc, a ubiquitous translation and transcription regulator which is found in a wide variety of proteins, is of great relevance to multiple chronic human and veterinary diseases. These include diabetes (and its effects in the heart, kidneys and eyes), cardiovascular disease, neurodegenerative disorders involving both plaque and tangle formation, inflammatory processes, liver disease, fibrosis, metabolic disorders and cancer. There is fast growing collection of evidence that O-GlcNAcylation plays a pivotal role in epigenetics.
From the laboratories of Geert-Jan Boons, PhD, Lance Wells, PhD, and Margreet A. Wolfert, PhD University of Georgia.
|Immunogen:||Synthetic peptide O-GlcNAc|
|Buffer:||Cell culture supernatant|
|Tested Applications:||ELISA, WB|
This antibody is part of a 23 Mab panel was developed specifically to study the diverse roles of O-GlcNAc and that can be employed for detection, isolation, and site localization. For details on antigen strategy, please consult: Chin Fen Teo, et al., Nat Chem Biol. 2010 May; 6(5): 338343. doi:10.1038/nchembio.338.
See all of the O-GlcNAc Antibodies here.
If you publish research with this product, please let us know so we can cite your paper.